NCT07186114View on ClinicalTrials.gov

A Prospective Study on the Therapeutic Outcomes of Mebo and Tantum Verde in Patients With Oral Mucositis

PHASE3CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

December 14, 2024

Study Completion Date

December 14, 2024

Conditions
Oral Mucositis (Ulcerative) Due to Radiation
Interventions
DRUG

MEBO Wound Ointment (MEBO)

MEBO® 0.25% Ointment (Gulf Pharmaceutical Industries) to be applied four times a day for two weeks

DRUG

Tantum Verde® mouthwash

Tantum verde (EIPICO®) mouthwash. Patients were asked to swish it for at least five minutes, four times daily for two weeks.

Trial Locations (2)

11553

Faculty of Dentistry - Cairo University, Cairo

Unknown

Cairo University, Cairo

All Listed Sponsors
lead

Cairo University

OTHER